Virtus ETF Advisers LLC Ac Immune Sa Transaction History

Virtus ETF Advisers LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$2.35 - $4.47 $72,882 - $138,632	-31,014 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$3.5 - $5.16 $6,433 - $9,484	-1,838 Reduced 5.59%	31,014 $124,000
Q4 2021 Feb 14, 2022	BUY	$4.83 - $7.56 $20,083 - $31,434	4,158 Added 14.49%	32,852 $163,000
Q3 2021 Nov 15, 2021	SELL	$6.2 - $8.34 $9,256 - $12,451	-1,493 Reduced 4.95%	28,694 $193,000
Q2 2021 Aug 10, 2021	BUY	$6.04 - $8.37 $182,329 - $252,665	30,187 New	30,187 $239,000

28.2M

150K

12.4K

Ticker ACIU
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 83,413,504
Market Cap $224M
Description
AC Immune SA, a clinical stage biopharmaceutical company, discovers, designs, and develops medicines and diagnostic products for the prevention and treatment of neurodegenerative diseases associated with protein misfolding. Its SupraAntigen and Morphomer platforms are designed to generate vaccines, antibodies, and small molecules, which selectiv...

Get notified when there are updates to the investment portfolio of Virtus ETF Advisers LLC, based on Form 13F filings with the SEC.

Stay updated on Virtus ETF Advisers LLC with notifications on news.